Atopic dermatitis management: comparing the treatment patterns of dermatologists in Japan, USA and UK

被引:19
作者
Baron, ED
Barzilai, D
Johnston, G
Kawashima, M
Takigawa, M
Nakagawa, H
Graham-Brown, RAC
Stevens, SR [1 ]
机构
[1] Univ Hosp Cleveland, Res Inst, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Cleveland, OH 44106 USA
[3] VA Med Serv, Cleveland, OH USA
[4] Epidemiol & Biostat, Cleveland, OH USA
[5] Leicester Royal Infirm, Leicester, Leics, England
[6] Tokyo Womens Med Univ, Tokyo, Japan
[7] Hamamatsu Univ Sch Med, Hamamatsu, Shizuoka 43131, Japan
[8] Jichi Med Sch, Minami Kawachi, Tochigi 32904, Japan
关键词
atopic dermatitis; treatment variation;
D O I
10.1046/j.1365-2133.2002.04895.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background The incidence of atopic dermatitis (AD) is increasing worldwide. No large-scale study has previously compared the therapeutic management of this condition in different countries. Objectives The purpose of this study was to determine the treatment preferences of dermatologists in Japan, the U.S.A. and the U.K., and investigate their relationship with certain factors pertaining to the physician and his practice. Methods A questionnaire was sent to all registered members of dermatological societies in Japan, the U.S.A. and the U.K. Responses were collated and statistical analysis performed using chi(2) , Mantel-Haenszel and Breslow heterogeneity tests. Results Three thousand six hundred and eighty-eight completed surveys were returned. U.S.A. and U.K. physicians were significantly more aggressive in prescribing systemic medications, such as steroids, antibiotics and immunosuppressants, compared with those in Japan. Japanese dermatologists also utilized topical steroids significantly less. The use of alternative remedies was highest in Japan. All three countries had a relatively high degree of optimism for topical immunosuppressants, but less so for other emerging therapies. Conclusions Both similarities and differences in the therapy of AD exist in the three countries studied. Factors related to the physician, patient population and culture may influence these observations.
引用
收藏
页码:710 / 715
页数:6
相关论文
共 22 条
[11]   Traditional Chinese medicine for the treatment of dermatologic disorders [J].
Koo, J ;
Arain, S .
ARCHIVES OF DERMATOLOGY, 1998, 134 (11) :1388-1393
[12]   ATOPIC-DERMATITIS IN CHILDREN - WHO CARES QUESTIONABLE WHO PAYS [J].
LAPIDUS, CS ;
SCHWARZ, DF ;
HONIG, PJ .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1993, 28 (05) :699-703
[13]   The occurrence of atopic dermatitis in North Europe: An international questionnaire study [J].
Larsen, FS ;
Diepgen, T ;
Svensson, A .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1996, 34 (05) :760-764
[14]   Cyclosporin in atopic dermatitis - Review of the literature and outline of a Belgian consensus [J].
Naeyaert, JM ;
Lachapelle, JM ;
Degreef, H ;
de la Brassinne, M ;
Heenen, M ;
Lambert, J .
DERMATOLOGY, 1999, 198 (02) :145-152
[15]   Tacrolimus - The drug for the turn of the millennium? [J].
Ruzicka, T ;
Assmann, T ;
Homey, B .
ARCHIVES OF DERMATOLOGY, 1999, 135 (05) :574-580
[16]   Systemic therapy of atopic dermatitis [J].
Sidbury, R ;
Hanifin, JM .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2000, 25 (07) :559-566
[17]   Old, new, and emerging therapies for atopic dermatitis [J].
Sidbury, R ;
Hanifin, JM .
DERMATOLOGIC CLINICS, 2000, 18 (01) :1-+
[18]   Atopic eczema: Its impact on the family and financial cost [J].
Su, JC ;
Kemp, AS ;
Varigos, GA ;
Nolan, TM .
ARCHIVES OF DISEASE IN CHILDHOOD, 1997, 76 (02) :159-162
[19]   Role of staphylococcal superantigens in atopic dermatitis: from colonization to inflammation [J].
Taskapan, MO ;
Kumar, P .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2000, 84 (01) :3-10
[20]  
Williams HC, 1999, CURR PROBL DERMATOL, V28, P9